Discovery
Building on our successful track record of delivering clinical candidates, we are expanding our medicinal chemistry service and introducing a new fragment screening platform, the CEfrag Screen
Selcia Discovery has significant research partnerships with leading pharmaceutical and biotechnology companies as well as academic institutions. We specialise in providing the medicinal chemistry resource for small biotech companies and academic institutions. At the same time we continue to expand our partnerships with major companies for drug discovery projects in all therapeutic areas.
We will be pleased to provide consultancy and advice to help with your grant and funding applications
Dr Bob Carling, Head of Medicinal Chemistry
Our synthetic chemistry work is backed up by the highest quality analytical service from our GLP accredited analytical laboratory. In addition all drug discovery activities are supported by internal functions, for example protein expression, structural biology, structural elucidation.
Selcia will be presenting a poster on their new fragment screening technology CEfragTM at the 5th Annual Drug Discovery Chemistry conference in San Diego USA from 27-29 April 2010.
Selcia will be exhibiting at the SBS 16th Annual Conference & Exhibition in Phoenix, Arizona, USA, from 11-15 April 2010.
Since 2008 Selcia Discovery has been working successfully on a EEDA funded drug discovery project.
